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No Benefit to Bicarbonate Hydration Prior to Angiography
Some studies suggest that hydration with sodium bicarbonate can reduce theincidence of contrast-induced nephropathy (CIN).Maoli and colleagues random-
ized 500 patientswith baseline creatinine clearance60ml/min to pre-hydrationwith
either saline or sodium bicarbonate. All patients received N-acetylcysteine (NAC).
There was no difference in the primary end point of CIN, defined as a rise0.5mg/dl
in creatinine. Hydration with sodium bicarbonate plus NAC before contrast exposure
is notmore effective than hydration with isotonic saline plusNAC at preventing CIN.
See page 599.
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Obesity and Heart Disease
Waist-to-Height Ratio Is Slightly Better Than BMI for CV Risk
Using body mass index (BMI) to define overweight and obesity may miss identi-fying persons at “normal” BMI levels with increased cardiovascular (CV) risk
related to central fat distribution. Using data from 2 large prospective cohorts (Physi-
cians’Health Study andWomen’sHealth Study), Gelber and colleagues examined the
predictive risk of several anthropometric indexes (BMI, waist circumference, waist-to-
hip ratio, and waist-to-height ratio [WHtR]). While WHtR was statistically the best,
the differences were small and not clinically significant. These findings emphasize that
higher levels of adiposity, however measured, confer increased risk of CV death and
that BMI can be used to measure this risk. See pages 605 and 616. See figure.
Lipid Reduction Therapy
Statin Therapy Alters the Relationship
Between ApoB and LDL and HDL Cholesterol
Apolipoprotein B (apoB) levels may better predict cardiovascular risk than low-density lipoprotein cholesterol (LDL-C). However, the relationship between
apoB and LDL-C may be altered by the concentration of small, dense low-density
lipoprotein particles or treatment with statins. Ballantyne and colleagues examined the
relationship between apoB and LDL-C before and after statin therapy. In untreated
patients, an apoB level 90 mg/dl was equivalent to an LDL-C level 100 mg/dl.
However, during statin therapy, it was necessary to reduce LDL-C to70 mg/dl (in
high-triglyceride patients) or 80 mg/dl (in lower-triglyceride patients). These data
suggest that in patients treated with statins, it is necessary to reduce LDL-C to 70
mg/dl to achieve apoB levels90 mg/dl. See pages 626 and 633.
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Cardiac Imaging
CTCA Has Poor Specificity for Functional Stenosis Severity
Meijboom and colleagues reviewed studies from patients who had undergoneboth computed tomography coronary angiography (CTCA) and traditional
coronary angiography (CA) with fractional flow reserve (FFR). Correlations between
quantitative computed tomography and quantitativeCAwith FFRmeasurementwere
weak. The diagnostic accuracy of qualitative CTCA to detect a lesion with an FFR
0.75was only 49%.CTCA can be used to exclude significant stenoses, but decisions
regarding the need for revascularization should include other modalities to determine
functional significance. See page 636. See figure.
Heart Failure
No Association Between Adrenergic Receptor
Polymorphisms and Survival in HF Patients
Therehave beendiscordant findings regarding the significance of genetic variationsin adrenergic receptors and outcomes in patients with systolic dysfunction.
Sehnert and colleagues genotyped over 600 patients with heart failure (HF) who were
treated with beta-blockers (metoprolol succinate or carvedilol). There were no signifi-
cant associationsbetweengenotypes orhaplotypes inADRB1,ADRB2, andADRA2C
and survival. These results do not support the clinical use of adrenergic receptor
genotypes to stratify outcomes or to individualize therapy. See pages 644 and
652.
